Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.
In allogeneic hematopoietic stem-cell transplantation (HSCT) recipients, outcome of human cytomegalovirus (HCMV) infection results from balance between viral load/replication and pathogen-specific T-cell response. Using a cut-off of 30,000 HCMV DNA copies/ml blood for pre-emptive therapy and cut-off...
Guardado en:
Autores principales: | Daniele Lilleri, Giuseppe Gerna, Paola Zelini, Antonella Chiesa, Vanina Rognoni, Angela Mastronuzzi, Giovanna Giorgiani, Marco Zecca, Franco Locatelli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/77a56ab237794f48bd4b18e32b10a1f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
por: Yi-Chang Liu, et al.
Publicado: (2021) -
Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.
por: Elisa Gabanti, et al.
Publicado: (2014) -
A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation
por: Paul J. Martin, et al.
Publicado: (2021) -
T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation
por: Takashi Toya, et al.
Publicado: (2020) -
Variable selection methods for predicting clinical outcomes following allogeneic hematopoietic cell transplantation
por: Chloé Pasin, et al.
Publicado: (2021)